Acadia Pharmaceutica (ACAD)

$45.61 0.14 (0.31%)

19:45 EDT ACAD Stock Quote Delayed 30 Minutes

Volume:

Previous Close $45.61

Market Cap 5.69B

PE Ratio -21.93

EPS -2.08

Volume (Avg. Vol.) 861,900

Day's Range 45.13 - 46.58

52-Week Range 21.56 - 53.70

Dividend & Yield N/A (N/A)

ACAD Stock Predictions, Articles, and Acadia Pharmaceutica News

From InvestorPlace
From the Web

10 Stocks to Buy for an Aging Population

By Will Ashworth, InvestorPlace Contributor Apr 28, 2020

Aging seniors have been put firmly in the crosshairs of the novel coronavirus. These 10 stocks to buy will benefit from this brutal reality.

7 Exciting Biotech Stocks to Buy Now

By Louis Navellier, Editor, Growth Investor Dec 2, 2019

Many of these biotech companies are beating the Nasdaq Biotech Index. With cutting-edge therapies, these are great names to buy.

5 Top Stock Trades for Wednesday: BA, ACB, PINS

By Bret Kenwell, InvestorPlace Contributor Sep 17, 2019

Boeing, Aurora Cannabis, Pinterest, Corning and Acadia Pharmaceuticals were our top stock trades on Wednesday. See the charts now.

7 Rising Healthcare Stocks to Consider

By Chris Lau, InvestorPlace Contributor Oct 29, 2018

Healthcare stocks recovered throughout 2018 but the recent correction in some big names is creating an entry point.

5 Big Pharma Stocks Investors Love Right Now

By Chris Lau, InvestorPlace Contributor Jul 13, 2018

The biotechnology and pharmaceutical sectors continue to offer great value for investors, and these five Big Pharma stocks stand out from the crowd.

Why ACADIA Pharmaceuticals Stock Is Falling Today

By Karl Utermohlen, InvestorPlace Writer Jul 9, 2018

ACADIA Pharmaceuticals (ACAD) stock was down more than 6% on Monday as an investigation was launched to examine the efficacy of one of its drugs.

Compare Brokers

Why ACADIA Pharmaceuticals Inc. Stock Is Plunging Today

By William White, InvestorPlace Writer Apr 9, 2018

ACADIA Pharmaceuticals(ACAD) stock was falling hard today on a report with concerns about its Parkinson's drug Nuplazid.

5 Biotech Stocks to Sell Amid the Latest Slaughter

By Anthony Mirhaydari, InvestorPlace Market Strategist Feb 28, 2018

These five biotech stocks are being hit particularly hard right now. Here's what investors should know about each of these stocks to sell.

5 Cheap Biotech Stocks to Snag on the Bounce

By Anthony Mirhaydari, InvestorPlace Market Strategist Dec 8, 2017

Biotech's luck is changing as the trend looks to be upward and outward for the biotech stocks. These are the five to watch.

Is Now the Time to Buy Into These 5 Biotech ETFs?

By Zacks Investment Research Mar 14, 2017

After a painful 2016, biotech stocks are recovering this year. What lies ahead? Let's look at 5 biotech ETFs to find out

3 Earnings Reports That Should Be on Your Radar

By Hilary Kramer, Editor, GameChangers Feb 24, 2017

Earnings season is far from over. In addition to crucial economic indicators, there are a few earnings reports to keep an eye on next week.

3 Big Mergers & Acquisitions That We Could See in 2017

By Laura Hoy, InvestorPlace Contributor Feb 1, 2017

2017 is likely to see quite a few mergers & acquisitions, and companies like BKS, NFLX and ACAD are all ripe for the M&A picking.

Compare Brokers

Acadia Pharmaceuticals Inc. (ACAD) Flirts With a Pfizer Inc. (PFE) Buyout

By John Kilhefner, Managing Editor, InvestorPlace.com Jan 4, 2017

Acadia stock took a big leap on rumors that Pfizer (PFE) is interested in a buyout. But ACAD stock investors shouldn't get too excited yet.

Hottest Manufacturing Stocks Now – MBRX ZYNE SID ONVO

By Portfolio Grader Dec 27, 2016

The following stocks were the biggest movers and shakers in the Manufacturing sector today.

Biggest Movers in Manufacturing Stocks Now – AKBA ABIO GLMD KMPH

By Portfolio Grader Dec 20, 2016

The Manufacturing sector saw plenty of trading activity today, including the following leaders and losers.

Hottest Manufacturing Stocks Now – OSIR ACAD AKAO VHI

By Portfolio Grader Nov 8, 2016

The following stocks were moving the Manufacturing sector today.

16 Best Stocks to Buy Under President Hillary Clinton

By Brian Nichols, InvestorPlace Contributor Oct 24, 2016

Could we see a President Hillary Clinton? According to most polls, that's the likeliest outcome for Nov. 8. Get your portfolio prepared with the 16 best stocks to buy ahead of another White House stint for the Clintons.

19 Biotechnology Stocks to Sell Now

By Portfolio Grader Oct 17, 2016

This week, the ratings of 19 Biotechnology stocks on Portfolio Grader are down. Each of these rates a "D" ("sell") or "F" overall ("strong sell").

Compare Brokers

10 Biotech Stocks to Put on Your Radar This Quarter

By James Brumley, InvestorPlace Feature Writer Oct 3, 2016

Q4 is usually a winner for biotech stocks, but these stocks could deliver more than their fair share of wins during the coming three months.

32 Biotechnology Stocks to Sell Now

By Portfolio Grader Sep 5, 2016

The ratings of 32 Biotechnology stocks are down this week, according to the Portfolio Grader database. Each of these rates a "D" ("sell") or "F" overall ("strong sell").

Navellier Ratings

Total Grade

Strong Buy

Premium Services

We are always here to help!

Not Yet a Subscriber?

Welcome

Welcome

Acadia Pharmaceutica (ACAD)

Navellier Ratings

Total Grade

Premium Services

We are always here to help!

Not Yet a Subscriber?

Welcome

Already a subscriber?

Welcome

Acadia Pharmaceutica (ACAD)

ACAD Stock Predictions, Articles, and Acadia Pharmaceutica News

Navellier Ratings

Total Grade

Subscriber Sign in